Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)
• By Region - North America, Europe, Asia
Pacific, Rest of the World. • By Country - U.S.A, Canada, Germany, U.K, Japan, China, India.
March 20191
Scope of the Report – Chemotherapy Drugs Market Historical
Forecast
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Antimetabolites
Plant Alkaloids
Alkylating Agents
Antitumor Antibiotics
Others
Oral
Intravenous
Others
Antimetabolites
Plant Alkaloids
Alkylating Agents
Antitumor Antibiotics
Others
Global
Market (By Value)
By Type of Drug, By Value
Regional
By Route of Administration, By Value
By Type of Drug, By Value
2
Scope of the Report – Chemotherapy Drugs Market Historical
Forecast
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Oral
Intravenous
Others
Regional
Market (By Value)
By Route of Administration, By Value
Pfizer Inc. (U.S.), Eli Lilly & Company (U.S.), Sanofi (France), Novartis (Germany), GlaxoSmithKline (U.K.), Bristol-Myers Squibb , Company Analysis
Teva Pharmaceuticals Industries (Japan), F. Hoffmann-La Roche Ltd ( Switzerland), Merck & Co., Inc. (U.S.), CELGENE CORPORATION (U.S.), Amgen Inc (U.S.), Takeda Pharmaceutical Company Limited (Japan),
Regional Analysis
North America, Europe, APAC and Rest of the World
Country Analysis
U.S.A, Canada, Germany, U.K, Japan, China and India.
3
Table of Content S.No
Particulars
Page No.
1.
Research Methodology
19
2.
Executive Summary
20
3.
Strategic Recommendation
21
3.1
Focus on promoting oral chemotherapy drugs
22
3.2
APAC region to witness augmented growth in the forecast period
23
4.
Chemotherapy Drugs Market Outlook
24
5.
Global Chemotherapy Drugs Market: Growth and Forecast
24
6.
5.1
By Value (2013-2017)
35
5.2
By Value (2018-2023)
36
Global Chemotherapy Drugs Market: Segmental Analysis
47
6.1
Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023)
49
6.2
Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023)
50
4
Table of Content S.No
7.
Particulars
Page No.
6.3
Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023)
51
6.4
Other Chemotherapy Drugs Market, By Value (2013-2023)
52
6.5
Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%)
53
6.5.1
Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)
55
6.5.2
Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%)
56
6.6
Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023)
57
6.6
Global Oral Chemotherapy Drugs Market, By Value (2013-2023)
58
6.7
Other Chemotherapy Drugs Market, By Value (2013-2023)
59
Global Chemotherapy Drugs Market: Regional Analysis 7.1
Global Chemotherapy Drugs Market Size, By Region : Breakdown (%)
60 61
7.1.1
Global Chemotherapy Drugs Market Size, By Region, 2017 (%)
62
7.1.2
Global Chemotherapy Drugs Market Size, By Region, 2023 (%)
63
5
Table of Content S.No
Particulars 7.2
7.3
7.4
Page No.
North America Chemotherapy Drugs Market: Growth and Forecast
64
7.2.1
By Value (2013-2017)
65
7.2.2
By Value (2018-2023)
66
7.2.3
By Type of Drug, By Value (2013-2017)
72
7.2.4
By Type of Drug, By Value (2018-2023)
73
7.2.5
By Route of Administration, By Value (2013-2017)
74
7.2.6
By Route of Administration, By Value (2018-2023)
75
North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada) 7.3.1
U.S Chemotherapy Drugs Market, By Value (2013-2023)
7.3.2
Canada Chemotherapy Drugs Market, By Value (2013-2023)
Europe Chemotherapy Drugs Market: Growth and Forecast
76 78
86
92
6
Table of Content S.No
Particulars
7.5
7.6
Page No.
7.4.1
By Value (2013-2017)
93
7.4.2
By Value (2018-2023)
94
7.4.3
By Type of Drug, By Value (2013-2017)
100
7.4.4
By Type of Drug, By Value (2018-2023)
101
7.4.5
By Route of Administration, By Value (2013-2017)
102
7.4.6
By Route of Administration, By Value (2018-2023)
103
Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K)
104
7.5.1
Germany Chemotherapy Drugs Market, By Value (2013-2023)
106
7.5.2
U.K Chemotherapy Drugs Market, By Value (2013-2023)
111
APAC Chemotherapy Drugs Market: Growth and Forecast 7.6.1
By Value (2013-2017)
116 117
7
Table of Content S.No
Particulars
7.7
7.8
Page No.
7.6.2
By Value (2018-2023)
118
7.6.3
By Type of Drug, By Value (2013-2017)
124
7.6.4
By Type of Drug, By Value (2018-2023)
125
7.6.5
By Route of Administration, By Value (2013-2017)
126
7.6.6
By Route of Administration, By Value (2018-2023)
127
APAC Chemotherapy Drugs Market: Country Analysis (India and China)
128
7.7.1
India Chemotherapy Drugs Market, By Value (2013-2023)
130
7.7.2
China Chemotherapy Drugs Market, By Value (2013-2023)
136
ROW Chemotherapy Drugs Market: Growth and Forecast
143
7.8.1
By Value (2013-2017)
144
7.8.2
By Value (2018-2023)
144
8
Table of Content S.No
8.
9.
Particulars
Page No.
7.8.3
By Type of Drug, By Value (2013-2017)
149
7.8.4
By Type of Drug, By Value (2018-2023)
150
7.8.5
By Route of Administration, By Value (2013-2017)
151
7.8.6
By Route of Administration, By Value (2018-2023)
152
Global Chemotherapy Drugs Market Dynamics
153
8.1
Global Chemotherapy Drugs Market Drivers
154
8.2
Global Chemotherapy Drugs Market Restraints
158
Global Chemotherapy Drugs Market Trends
161
10.
Porter Five Force Analysis
162
11.
SWOT Analysis
164
12.
Policy and Regulatory Landscape
166
9
Table of Content S.No
14.
15.
Particulars
Company Profiling
Page No.
177
14.1
Pfizer
178
14.2
Eli Lilly & Company
181
14.3
CELGENE Corporation
183
14.4
Bristol-Myers Squibb
186
14.5
Merck & Co., Inc.
188
14.6
GlaxoSmithKline plc
190
14.7
Novartis
192
14.8
Sanofi
194
14.9
Teva Pharmaceuticals Industries Limited
196
About Us
198
10
List of Figures Figure No.
Figure Title
Page No.
Figure 1:
Common Treatment Modalities for Cancer
11
Figure 2:
Cancer Treatment Flowchart
28
Figure 3:
Chemotherapy Drugs Market Segmentation Flowchart
33
Figure 4:
Global Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
35
Figure 5:
Global Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
36
Figure 6:
Key factors driving of change in the global oncology market
37
Figure 7:
Projected global population (In Billions)
38
Figure 8:
Population ages 65 and above, By Select Region, 2013-2017 (% of total)
38
Figure 9:
Projected global population aged 60 years & above (In Billions)
38
Figure 10:
Global Health Expenditure Per Capita, By Select Countries, 2016 (In USD)
39
Figure 11:
Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
39
Figure 12:
Global Burden of Cancer
40
Figure 13:
Prevalence and Epidemiology of Cancer Worldwide
41
Figure 14:
5 Year Survival Rate, Breast and Colorectal Cancer
41
Figure 15:
Types of cancer for which clinical trials using chemotherapy drugs treatment are being conducted
42
Figure 16:
Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
43
Figure 17:
Global Prevalence of Prostate Cancer (2013-2017, Thousands)
43
Figure 18:
Oncologists per 1 Million of Population, By Select Country, 2018
44
Figure 19:
Availability of New Cancer Drugs Launched in 2012-2016, By Select Country (As of 2017)
45
Figure 20:
Global Antimetabolite Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
49
11
List of Figures Figure No.
Figure Title
Page No.
Figure 21:
Global Antimetabolite Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
49
Figure 22:
Global Plant Alkaloid Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
50
Figure 23:
Global Plant Alkaloid Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
50
Figure 24:
Global Alkylating Agent Drugs Market, By Value, 2013-2017 (USD Million)
51
Figure 25:
Global Alkylating Agent Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
51
Figure 26:
Global Anti-tumor Antibiotic Drugs Market, By Value, 2013-2017 (USD Million)
52
Figure 27:
Global Anti-tumor Antibiotic Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
52
Figure 28:
Other Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
53
Figure 29:
Other Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
53
Figure 30:
Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)
55
Figure 31:
Global Chemotherapy Drugs Market Size,By Route of Administration, 2023 (%)
56
Figure 32:
Global Intravenous Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
57
Figure 33:
Global Intravenous Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
57
Figure 34:
Global Oral Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
58
Figure 35:
Global Oral Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
58
Figure 36:
Other Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
59
Figure 37:
Other Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
59
Figure 38:
Global Chemotherapy Drugs Market Size, By Region, 2017 (%)
62
Figure 39:
Global Chemotherapy Drugs Market Size, By Region, 2023 (%)
63
Figure 40:
North America Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
65
12
List of Figures Figure No.
Figure Title
Page No.
Figure 41:
North America Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
66
Figure 42:
North America GDP, 2012-2017 (USD Trillion)
68
Figure 43:
North America GDP per capita, current prices, 2013-2023F (In USD)
68
Figure 44:
Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
69
Figure 45:
North America, Cancer Incidence (In Millions)
70
Figure 46:
North America, Cancer Incidence, By Route of Administration, 2019E (In %)
70
Figure 47:
North America Population above 65 year, 2015, 2030F, & 2050F (In Millions)
70
Figure 48:
North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
72
Figure 49:
North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
73
Figure 50:
North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
74
Figure 51:
North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
75
Figure 52:
U.S. Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
78
Figure 53:
Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
79
Figure 54:
Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
79
Figure 55:
Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
80
Figure 56:
Estimated New Cases of Cancer in the United States, 2014-2018 (In Thousands)
80
Figure 57:
Estimated New Cases of Cancer in the United States, By State, 2018
81
Figure 58:
Estimated Numbers of US Cancer Survivors (As of January 1, 2016)
82
Figure 59:
Estimated Numbers of US Cancer Survivors (As of January 1, 2026F)
83
Figure 60:
Factors Influencing Patient Out-of-Pocket Costs for Cancer Medicines
84
List of Figures Figure No.
Figure Title
Page No.
Figure 61:
United States, Top Players in the chemotherapy drugs market, By Company Share, 2017 (%)
85
Figure 62:
Canada Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
86
Figure 63:
Cancer Burden in Canada, 2017
87
Figure 64:
Prevalence of Different Type of Cancer in Canada, 2016 & 2017 ( In Hundreds)
88
Figure 65:
Cancer Fact Sheet of Canada, 2017
88
Figure 66:
Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
89
Figure 67:
Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
89
Figure 68:
North America Chemotherapy Drugs Market, Country Share, 2013-2017 (% of Total)
90
Figure 69:
North America Chemotherapy Drugs Market, Country Share, 2018F-2023F (% of Total)
91
Figure 70:
Europe Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
93
Figure 71:
Europe Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
94
Figure 72:
Europe, Cancer Incidence, 2019E-2035F (In Millions)
95
Figure 73:
Europe, Cancer Incidence, By Type, 2019E
95
Figure 74:
Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Thousands)
96
Figure 75:
Europe, Per Capita Health Expenditure, By Select Country, 2017 (USD)
97
Figure 76:
GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
97
Figure 77:
Breakdown of Total Health Expenditure in Europe, 2018 (%)
98
Figure 78:
Major Players in Chemotherapy Drugs Market in Europe
98
Figure 79:
Europe Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
100
Figure 80:
Europe Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
101
List of Figures Figure No.
Figure Title
Page No.
Figure 81:
Europe Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
102
Figure 82:
Europe Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
103
Figure 83:
Germany Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
106
Figure 84:
Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
108
Figure 85:
Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
109
Figure 86:
U.K Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
111
Figure 87:
Cancer Statistics in the United Kingdom
112
Figure 88:
U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
113
Figure 89:
Europe Chemotherapy Drugs Market, Country Share, Historic, 2013-2017(% of Total)
114
Figure 90:
Europe Chemotherapy Drugs Market, Country Share, Forecast, 2018-2023 (% of Total)
115
Figure 91:
APAC Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
117
Figure 92:
APAC Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
118
Figure 93:
Estimated number of deaths from prostate cancer in 2012 and 2030
120
Figure 94:
World health expenditure as % of GDP
120
Figure 95:
Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)
121
Figure 96:
Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
121
Figure 97:
APAC, GDP, By Select Country, 2017 (In USD Trillion)
121
Figure 98:
APAC Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
124
Figure 99:
APAC Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
125
APAC Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
126
Figure 100:
15
List of Figures Figure No.
Figure Title
Page No.
Figure 101:
APAC Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
127
Figure 102:
India Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
130
Figure 103:
Key factors affecting the Indian Healthcare Industry
131
Figure 104:
India, Total Population, 2013-2023F (In Billion)
132
Figure 105:
India, Share of Urban Population, 2012-2017 (In %)
132
Figure 106:
India, GDP Growth Per Year, 2015-2019 (In %)
133
Figure 107:
India, Total deaths due to cancer, 2018
133
Figure 108:
Top 5 forms of cancer in men and women in India
133
Figure 109:
China Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
136
Figure 110:
China, GDP Growth Per Year, 2015-2019 (In %)
137
Figure 111:
China, Share of Urban Population, 2012-2017 (In %)
137
Figure 112:
China, Total Population, 2013-2021F (In Billion)
137
Figure 113:
Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
138
Figure 114:
Number of new cases, Males (all ages), 2018 (In %)
139
Figure 115:
Number of new cases, Females (all ages), 2018 (In %)
139
Figure 116:
China, Cancer Mortality Rate, By Cancer Site, 2018
140
Figure 117:
APAC Chemotherapy Drugs Market, Country Share, Historic, 2013-2017 (% of Total)
141
Figure 118:
APAC Chemotherapy Drugs Market, Country Share, Forecast, 2018-2023 (% of Total)
142
Figure 119:
ROW Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
144
Figure 120:
Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
145
16
List of Figures Figure No.
Figure Title
Page No.
Figure 121:
Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
145
Figure 122:
Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
146
Figure 123:
Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
147
Figure 124:
ROW Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
149
Figure 125:
ROW Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
150
Figure 126:
ROW Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
151
Figure 127:
ROW Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
152
Figure 128:
Drug Discovery and Development, Approximate Timeline
176
Figure 129:
Pfizer, Revenue, 2013-2017 (In USD Billion)
179
Figure 130:
Pfizer, Revenue, By Business Segment, 2017 (In %)
179
Figure 131:
Pfizer, Revenue, By National Market, 2015-2017 (In %)
179
Figure 132:
Pfizer, Oncology Revenue, 2015-2017 (In USD Million)
180
Figure 133:
Eli Lilly & Company, Revenue, 2013-2017 (In USD Billion)
182
Figure 134:
Eli Lilly & Company, Revenue, By Business Segment, 2017 (In %)
182
Figure 135:
Eli Lilly & Company, Net Sales, By Geographic Region, 2017 (In %)
182
Figure 136:
CELGENE Corporation, Revenue, 2013-2017 (In USD Million)
184
Figure 137:
CELGENE Corporation, Net Sales, By Geographic Region, 2017 (In %)
184
Figure 138:
Bristol-Myers Squibb, Revenue, 2013-2017 (In USD Million)
187
Figure 139:
Bristol-Myers Squibb, Revenue, By Business Segment, 2017 (In %)
187
Figure 140:
Bristol-Myers Squibb, Net Sales, By Geographic Region, 2017 (In %)
187
17
List of Figures Figure No.
Figure Title
Page No.
Figure 141:
Merck & Co., Inc., Revenue, 2013-2017 (In USD Million)
189
Figure 142:
Merck & Co., Inc., Net Sales, By Geographic Region, 2017 (In %)
189
Figure 143:
GlaxoSmithKline plc, Revenue, 2013-2017 (In USD Million)
191
Figure 144:
GlaxoSmithKline plc, Revenue, By Business Segment, 2017 (In %)
191
Figure 145:
GlaxoSmithKline plc, Net Sales, By Geographic Region, 2017 (In %)
191
Figure 146:
Novartis, Revenue, 2014-2018 (In USD Million)
193
Figure 147:
Novartis, Net Sales, By Business Segment, 2017 (In %)
193
Figure 148:
Sanofi, Revenue, 2013-2017 (In USD Million)
195
Figure 149:
Sanofi , Revenue, By Business Segment, 2017 (In %)
195
Figure 150:
Sanofi, Net Sales, By Geographic Region, 2017 (In %)
195
Figure 151:
Teva Pharmaceutical INDUSTRIES LIMITED, Revenue, 2013-2017 (In USD Million)
197
Figure 152:
Teva Pharmaceutical INDUSTRIES LIMITED, Revenue, By Business Segment, 2017 (In %)
197
Figure 153:
Teva Pharmaceutical INDUSTRIES LIMITED, Net Sales, By Geographic Region, 2017 (In %)
197
Table A:
Approach and Limitations of Common Treatment Modalities for Cancer
27
Table B:
Recent Company Acquisitions and Mergers in Chemotherapy Drugs Market
46
Table C:
Germany, Healthcare Related Statistics, 2017
108
Table D:
Estimated number of people living with cancer, 2020F and 2030F
113
Table E:
Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
122
Table F:
India, Cancer Statistics
134
18
Research Methodology For our study on global chemotherapy drugs market, we have conducted comprehensive secondary research followed by an extensive primary research. In the process of
secondary research, we have scrutinized
industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of pharmaceutical and healthcare industry.
Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies were scanned to further validate the market size and to estimate the size of various other
end-user sectors. Market sizing and growth in the forecast period (2018-2023) is estimated through product mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources.
Report Focus: Global Chemotherapy Drugs Market - By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics and Others) - By Route of Administration (Oral, Intravenous and Others) - By Region (North America, Europe, Asia Pacific and Rest of the World) - By Country ( U.S., Canada, U.K, Germany, China and India). Companies Contacted: Eli Lilly & Company, Shilpa Medicare
19
Chemotherapy Drugs Market: Product Outlook Figure 2: Cancer Treatment Flowchart
PreCancer
Screening Diagnostics
Cancer
Companion Diagnostics
Immuno-therapy
Targeted Drugs
Surgery
Chemotherapy
Radiotherapy
Source: Azoth Analytics Estimates
20
Chemotherapy Drugs Market: Product Outlook Figure 3: Chemotherapy Drugs Market Segmentation Flowchart
Antimetabolites
Plant Alkaloids
By Type of Drug
Alkylating Agents
Antitumor Antibiotics
Others
Chemotherapy Drugs Market
Oral
By Route of Administration
Intravenous
Others Source: Azoth Analytics Estimates
21
Global Chemotherapy Drugs Market Overview Rapidly growing incidence of cancer worldwide in concurrence with rising expenditure on healthcare has been boosting the chemotherapy drugs market on a global level. Figure 4: Global Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million) CAGR 2013-2017 xx%
2013
2014
2015
2016
2017
Source: Azoth Analytics Estimates Xx Xx
Xx Xx Xx Xx
22
Global Chemotherapy Drugs Market Rising availability of lower priced generic versions of blockbuster chemotherapy drugs across the globe is likely to drive the demand growth in the forecast period.
Figure 5: Global Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million) CAGR 2018-2023 xx%
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx
23
Global Antimetabolite Drugs Market Global Chemotherapy Drugs Market Chemotherapy Replacement Devices Market, By Value Figure 20: Global Antimetabolite Chemotherapy
Figure 21: Global Antimetabolite Chemotherapy Drugs
Drugs Market, By Value, 2013-2017 (USD Million)
Market, By Value, Forecast, 2018-2023 (USD Million)
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates Xx Xx Xx
Xx Xx Xx Xx Xx
24
Global Plant Drugs Market Global Chemotherapy DrugsAlkaloid MarketChemotherapy Replacement Devices Market, By Value Figure 22: Global Plant Alkaloid Chemotherapy Drugs
Figure 23: Global Plant Alkaloid Chemotherapy Drugs
Market, By Value, 2013-2017 (USD Million)
Market, By Value, Forecast, 2018-2023 (USD Million)
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates Xx Xx Xx
Xx Xx Xx Xx Xx
25
Drugs Market Global ChemotherapyGlobal DrugsAlkylating Market Agent Replacement Devices Market, By Value Figure 24: Global Alkylating Agent Drugs Market, By
Figure 25: Global Alkylating Agent Drugs Market, By
Value, 2013-2017 (USD Million)
Value, Forecast, 2018-2023 (USD Million)
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates Xx Xx Xx
Xx Xx Xx Xx Xx
26
Global Anti-tumor Drugs Market Global Chemotherapy Drugs Market Antibiotic Replacement Devices Market, By Value Figure 26: Global Anti-tumor Antibiotic Drugs Market,
Figure 27: Global Anti-tumor Antibiotic Drugs Market,
By Value, 2013-2017 (USD Million)
By Value, Forecast, 2018-2023 (USD Million)
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates Xx Xx Xx
Xx Xx Xx Xx Xx
27
Other Chemotherapy Drugs Market Global Chemotherapy Drugs Market Replacement Devices Market, By Value Figure 28: Other Chemotherapy Drugs Market, By
Figure 29: Other Chemotherapy Drugs Market, By
Value, 2013-2017 (USD Million) CAGR 2013-2017
Value, Forecast, 2018-2023 (USD Million) CAGR 2018-2023
xx%
xx%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Xx Xx
Source: Azoth Analytics Estimates
Xx
Xx Xx Xx Xx Xx
28
Global Chemotherapy Drugs Market- By Route of Administration Intravenously administered chemotherapy drugs held the major market share of approximately 75.58%, by value, in the year 2017.
Key Drivers Figure 30: Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%) xx
Oral
Intravenous
xx
Others
Source: Azoth Analytics Estimates xx
29
Global Chemotherapy Drugs Market- By Route of Administration In the forecast period, the segment of orally administered chemotherapy drugs is expected to witness fastest growth.
Key Drivers
Figure 31: Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%) xx
Oral
Intravenous
xx
Others
xx Source: Azoth Analytics Estimates
30
GlobalDrugs Intravenous Chemotherapy Drugs MarketMarket, By Value Global Chemotherapy Market Replacement Devices Figure 32: Global Intravenous Chemotherapy Drugs
Figure 33: Global Intravenous Chemotherapy Drugs
Market, By Value, 2013-2017 (USD Million)
Market, By Value, Forecast, 2018-2023 (USD Million)
2013
2014
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2015
2016
2017
2018
2019
2020
2021
2022
2023
Xx Source: Azoth Analytics Estimates Xx Xx
Xx Xx Xx Xx Xx
31
Global Oral Chemotherapy Drugs Market Global Chemotherapy Drugs Market Replacement Devices Market, By Value Figure 34: Global Oral Chemotherapy Drugs Market,
Figure 35: Global Oral Chemotherapy Drugs Market,
By Value, 2013-2017 (USD Million)
By Value, Forecast, 2018-2023 (USD Million)
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2013
Xx
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates
Xx Xx
Xx Xx Xx Xx Xx
32
Other Chemotherapy Drugs Market Global Chemotherapy Drugs Market Replacement Devices Market, By Value Figure 36: Other Chemotherapy Drugs Market, By
Figure 37: Other Chemotherapy Drugs Market, By
Value, 2013-2017 (USD Million)
Value, Forecast, 2018-2023 (USD Million)
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Xx Xx
Source: Azoth Analytics Estimates
Xx Xx Xx Xx Xx Xx
33
Global Chemotherapy Drugs Market- Regional Analysis Developed regions such as North America and Europe held more than 70% share in the global chemotherapy drugs market, by value, in the year 2017.
Key Drivers
Figure 38: Global Chemotherapy Drugs Market Size, By Region, 2017 (%) xx
North America
Europe xx
APAC
ROW xx Source: Azoth Analytics Estimates
34
Global Chemotherapy Drugs Market- Regional Analysis In the forecast period, North America region is expected to hold it’s dominant position in the market. However, Asia-Pacific market is anticipated to advance at the highest pace.
Figure 39: Global Chemotherapy Drugs Market
Key Drivers
Size, By Region, 2023 (%)
xx
North America
Europe
xx
APAC
ROW xx Source: Azoth Analytics Estimates
35
North America Chemotherapy Drugs Market Overview Heavy investments in the research & development of innovative chemotherapy drugs together with high per capita expenditure on healthcare have been the key factors backing the regional market. Figure 40: North America Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million) CAGR 2013-2017 xx%
2013
Xx
2014
2015
2016
2017
Source: Azoth Analytics Estimates
Xx
Xx Xx Xx Xx
36
North America Chemotherapy Drugs Market Overview Noteworthy growth in the regional market is attributed to favourable reimbursement policies in the region in addition to high focus on international sales, mergers and acquisitions. Figure 41: North America Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million) CAGR 2018-2023 xx%
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx
37
North America Chemotherapy Drugs Market, By Type of Drug Figure 48: North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million) CAGR 2013-2017 Antimetabolites: xx% Plant Alkaloids: xx%
Alkylating Agents: xx% Antitumor Antibiotics : xx% Others: xx%
2013
Antimetabolites
2014
2015
Plant Alkaloids
2016
Alkylating Agents
2017
Anti-tumor Antibiotics
Others
2013
2014
2015
2016
2017
Antimetabolites
xx
xx
xx
xx
xx
Plant Alkaloids
xx
xx
xx
xx
xx
Alkylating Agents
xx
xx
xx
xx
xx
Antitumor Antibiotics
xx
xx
xx
xx
xx
Others
xx
xx
xx
xx
xx
Xx Xx Xx Xx Source: Azoth Analytics Estimates
38
North America Chemotherapy Drugs Market, By Type of Drug Figure 49: North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million) CAGR 2018-2023 Antimetabolites: xx% Plant Alkaloids: xx%
Alkylating Agents: xx% Antitumor Antibiotics : xx% Others: xx%
2018 Antimetabolites
2019
2020
Plant Alkaloids
2021 Alkylating Agents
2022
2023
Anti-tumor Antibiotics
Others
2018
2019
2020
2021
2022
2023
Antimetabolites
xx
xx
xx
xx
xx
xx
Plant Alkaloids
xx
xx
xx
xx
xx
xx
Alkylating Agents
xx
xx
xx
xx
xx
xx
Antitumor Antibiotics
xx
xx
xx
xx
xx
xx
Others
xx
xx
xx
xx
xx
xx
Xx Xx Xx
Source: Azoth Analytics Estimates
39
North America Chemotherapy Drugs Market, By Route of Administration Figure 50: North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
CAGR 2013-2017 Oral: xx% Intravenous: xx% Others: xx%
2013
2014
2015
Oral
2016
Intravenous
2017 Others
2013
2014
2015
2016
2017
Oral
xx
xx
xx
xx
xx
Intravenous
xx
xx
xx
xx
xx
Others
xx
xx
xx
xx
xx
Xx Xx Xx Xx
Source: Azoth Analytics Estimates
40
North America Chemotherapy Drugs Market, By Route of Administration Figure 51: North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
CAGR 2018-2023 Oral: xx% Intravenous: xx% Others: xx%
2018
2019
2020
Oral
2021
2022
Intravenous
2023
Others
2018
2019
2020
2021
2022
2023
Oral
xx
xx
xx
xx
xx
xx
Intravenous
xx
xx
xx
xx
xx
xx
Others
xx
xx
xx
xx
xx
xx
Xx Xx Xx Xx
Source: Azoth Analytics Estimates
41
U.S. Chemotherapy Drugs Market, By Value Figure 52: U.S. Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
2013
Xx
2014
CAGR 2013-2017
CAGR 2018-2023
xx%
xx%
2015
2016
2017
2018
2019
2020
2021
2022
2023
Source: Azoth Analytics Estimates
Xx Xx
Xx Xx •
.
Xx Xx Xx
42
About Azoth Analytics Pvt Ltd.
Azoth Analytics (ISO 9001:2015) is a business research and analytics company that creates in-depth research reports and provides customized research solutions and consulting services. An ISO 9001:2015 certified company, Azoth Analytics adheres to international quality management standard and has strong commitment to a culture of continuous improvement. The business research and market analysis of Azoth Analytics helps organizations across different industry verticals solve their business problems. Strategic market sizing and data dredging techniques include secondary research, and primary research
(interviews with management personnel and industry experts). Azoth Analytics provide syndicated and customized market research reports on different verticals including pharmaceutical and healthcare, oil and gas and power, chemicals, automotive, technology, FMCG, food & beverages and media sectors.
(c) AZOTH Analytics
43